OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2024
(3)
2021
(3)
2022
(2)
2017
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Not available
S-EPMC5731244
|
biostudies-literature
Cite
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study.
Not available
S-EPMC9164243
|
biostudies-literature
Cite
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism.
Not available
S-EPMC8649245
|
biostudies-literature
Cite
Assessment of bleeding events in patients receiving DOACs with or without statins to treat venous thromboembolism: insights from the RIETE registry.
Not available
S-EPMC11590820
|
biostudies-literature
Cite
Right ventricular-pulmonary artery coupling for prognostication in acute pulmonary embolism.
Not available
S-EPMC11666307
|
biostudies-literature
Cite
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
Not available
S-EPMC7995808
|
biostudies-literature
Cite
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
Not available
S-EPMC12056793
|
biostudies-literature
Cite
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.
Not available
S-EPMC8206995
|
biostudies-literature
Cite
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
Not available
S-EPMC8652887
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets